Anticipated opening in summer 2022 will bring some 200 jobs to
Connecticut and a state-of-the-art innovation center, among other
benefits to the state
Philip Morris International (PMI) (NYSE:PM) today announced that
its new corporate headquarters will be located in the heart of
Stamford, Connecticut, and is expected to open in summer 2022. The
move is a notable component of PMI’s transformation to a smoke-free
company and—with the support of Gov. Ned Lamont (D) and the
company’s leadership—will initially bring approximately 200 jobs to
help fuel the state’s continued economic growth. The total economic
impact of these jobs is expected to be approximately $50 million in
2022.
“Connecticut’s position as a leader in innovation and forward
thinking, paired with a commitment to open-minded civil discourse,
allows us to foster an even stronger company culture. PMI will
continue to attract an educated workforce, becoming an integral
part of the local community and a source of pride for the state,”
said Deepak Mishra, President of the Americas Region at PMI.
“We are making rapid progress toward our smoke-free future,”
continued Mishra, “and our new base in Connecticut is more than
just an office building—it will be a full campus with a
state-of-the-art innovation facility that will help accelerate our
transformation.” State officials recognize that PMI is a company
with a new purpose and bright future. We are proud that we will be
able to call Connecticut home.”
The new 71,484 square foot headquarters will be located at 677
Washington Boulevard in the heart of Stamford’s central business
district, steps away from the Stamford Transportation Center and
the entrance to I-95, making it easily accessible. The office will
open as home to the PMI Americas region and other corporate
functions. PMI’s Operations Center will remain in Lausanne,
Switzerland, to continue to support the business across the globe.
The company employs a worldwide workforce of more than 71,000.
"The decision by PMI to locate its corporate headquarters in
downtown Stamford is validation that our economic recovery in
Connecticut is in full swing, and we are continuing to see
meaningful growth in one of our fastest growing cities," said
Governor Ned Lamont. "We are looking forward to a long and fruitful
relationship with PMI and it is clear they are focused on
maintaining a strong partnership with the State of Connecticut for
the foreseeable future."
The Connecticut location will offer employees a better range of
commuting and living options following the paradigm shift caused by
COVID-19. The headquarters will be aligned with PMI’s science- and
technology-focused transformation, using state-of-the-art
innovation to accommodate remote work and ensure that employees
have an inspiring and comfortable workplace.
“We are excited that our new location will offer employees and
their families a wide range of living options, from the suburbs of
Fairfield County to the rural areas of Litchfield County, while
also having the advantages of easy access to the New York
metropolitan area. More encouraging are the pioneering and
community-minded populace, an excellent school system and
healthcare facilities, and ample recreational and green space,”
said Charles Bendotti, Senior Vice President of People and Culture
at PMI.
PMI will take possession on March 1, 2022, with the goal of
having the office operational by mid-to-late summer 2022.
PMI is widely recognized as a top employer and a leader in
gender equity, equitable pay, and environmental, social, and
corporate governance (ESG) measures. Recognitions include:
- The first international company to achieve global EQUAL-SALARY
certification
- Included in the 2021 Bloomberg Gender-Equality Index
- Certified Global Top Employer for five consecutive years by
the Top Employers Institute
- Ranked on CDP’s A List for climate change for seven years in a
row
- Included in the Dow Jones Sustainability Index North
America
- Awarded CDP’s “triple A” score in 2020 for efforts to combat
climate change and the protection of forests and water security
Since 2016, PMI has undergone a major business transformation,
moving away from cigarettes and other combustible tobacco products
in favor of smoke-free alternatives that, while not risk-free, are
scientifically substantiated to be a better choice than continued
smoking. PMI is committed to a smoke-free future, and its
noncombustible products already accounted for nearly 30% of net
revenues in the third quarter of 2021. Building on this progress,
the company has accelerated its ambitions, now aiming to be a
majority smoke-free company in terms of net revenues by the end of
2025.
The potential public health impact of PMI’s scientifically
substantiated smoke-free products is increasingly being recognized
by governments and public health authorities. For instance, in the
U.S., the Food and Drug Administration (FDA) has issued marketing
authorizations for IQOS, PMI’s electronically heated tobacco
system. In July 2020, the FDA authorized the IQOS 2.4 system as a
Modified Risk Tobacco Product (MRTP), concluding that issuing
exposure modification orders for the system is “appropriate to
promote the public health” and is “expected to benefit the health
of the population as a whole.” The agency is now conducting a
scientific review of the company’s MRTP application for the IQOS 3
system, which was authorized for sale in the U.S. in December
2020.
Globally, as of September 30, 2021, an estimated 14.9 million
adults have switched to IQOS and stopped smoking.
Note to editor:
In the U.S., Altria Group, Inc. has a license to market
IQOS.
Philip Morris International: Delivering a Smoke-Free Future
Philip Morris International (PMI) is leading a transformation in
the tobacco industry to create a smoke-free future and ultimately
replace cigarettes with smoke-free products to the benefit of
adults who would otherwise continue to smoke, society, the company,
its shareholders, and other stakeholders. PMI is a leading
international tobacco company engaged in the manufacture and sale
of cigarettes, as well as smoke-free products, associated
electronic devices and accessories, and other nicotine-containing
products in markets outside the U.S. In addition, versions of PMI’s
IQOS Platform 1 device and consumables have received marketing
authorizations from the U.S. Food and Drug Administration (FDA)
under the premarket tobacco product application (PMTA) pathway; the
FDA has also authorized the marketing of a version of IQOS and its
consumables as a Modified Risk Tobacco Product (MRTP), finding that
an exposure modification order for these products is appropriate to
promote the public health. PMI is building a future on a new
category of smoke-free products that, while not risk-free, are a
much better choice than continuing to smoke. Through
multidisciplinary capabilities in product development,
state-of-the-art facilities, and scientific substantiation, PMI
aims to ensure that its smoke-free products meet adult consumer
preferences and rigorous regulatory requirements. PMI’s smoke-free
product portfolio includes heat-not-burn products,
nicotine-containing vapor products, and oral nicotine products. As
of September 30, 2021, PMI’s smoke-free products are available for
sale in 70 markets in key cities or nationwide, and PMI estimates
that approximately 14.9 million adults around the world have
already switched to IQOS and stopped smoking. For more information,
please visit www.pmi.com and www.pmiscience.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211108005645/en/
Philip Morris International Corey Henry Corey.henry@pmi.com
(202) 679-7296
P M I (NYSE:PMI)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025
P M I (NYSE:PMI)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025